Differential effects of estradiol and progesterone on human T cell activation in vitroShow others and affiliations
2021 (English)In: European Journal of Immunology, ISSN 0014-2980, E-ISSN 1521-4141, Vol. 51, no 10, p. 2430-2440Article in journal (Refereed) Published
Abstract [en]
Estradiol (E2) and progesterone (P4) are steroid hormones important for the regulation of immune responses during pregnancy. Their increasing levels coincide with an improvement of T cell-mediated diseases such as multiple sclerosis (MS). Although immune-endocrine interactions are involved in this phenomenon, the relative contribution of hormones is not known. We here report a direct comparison of E2- and P4-mediated effects on human CD4+ T cells, key cells in immune regulation. T cells were stimulated to obtain different activation levels and exposed to a broad range of hormone concentrations. Activation level was assessed by CD69/CD25 expression by flow cytometry, and secreted proteins (n = 196) were measured in culture supernatants using proximity extension assay and electrochemiluminescence immunoassay. We found that in low activated cells, pregnancy-relevant E2 concentrations increased activation and the secretion of several immune- and inflammation-related proteins. P4, on the other hand, showed a biphasic pattern, where serum-related concentrations upregulated activation and protein secretion while placenta-relevant concentrations induced a prominent dampening irrespective of the initial activation level. Our results demonstrate the importance of P4 as a major hormone in the immune modulation of T cells during pregnancy and emphasize the need to further evaluate its potency in the treatment of diseases like MS.
Place, publisher, year, edition, pages
Wiley-VCH Verlagsgesellschaft, 2021. Vol. 51, no 10, p. 2430-2440
Keywords [en]
CD4+ T cell activation, estrogen, human, progesterone, proteomics
National Category
Obstetrics, Gynecology and Reproductive Medicine
Identifiers
URN: urn:nbn:se:oru:diva-93496DOI: 10.1002/eji.202049144ISI: 000678786600001PubMedID: 34223649Scopus ID: 2-s2.0-85111169360OAI: oai:DiVA.org:oru-93496DiVA, id: diva2:1584054
Funder
Swedish Foundation for Strategic Research , SB16-0011Swedish Research Council, 2018-02776European CommissionSwedish Society of Medicine, SLS-879791
Note
Funding agencies:
Swedish Lions Research Foundation
Swedish Foundation for MS Research
2021-08-102021-08-102024-01-02Bibliographically approved